TGF‐β signaling is well established to play a critical role in PDAC, as evidenced by the frequent mutations in SMAD4, a tumor suppressor gene encoding a transcription factor that is a central mediator of the TGF‐β pathway [40]. The gene discussed is SMAD4; the disease is neoplasm.